Schirò, G.; Gastaldi, M.; Iacono, S.; Scaranzin, S.; Picciolo, V.; Arnao, V.; Ferrari, A.; Gagliardo, C.; D’Amelio, M.
Anti-Collapsin Response Mediator Protein 5(CV2/CRMP5) and Anti-Glutamic Acid Decarboxylase (GAD) Antibodies-Mediated Encephalopathy Mimicking Atypical Parkinsonism. Neurol. Int. 2024, 16, 1849-1855.
https://doi.org/10.3390/neurolint16060132
AMA Style
Schirò G, Gastaldi M, Iacono S, Scaranzin S, Picciolo V, Arnao V, Ferrari A, Gagliardo C, D’Amelio M.
Anti-Collapsin Response Mediator Protein 5(CV2/CRMP5) and Anti-Glutamic Acid Decarboxylase (GAD) Antibodies-Mediated Encephalopathy Mimicking Atypical Parkinsonism. Neurology International. 2024; 16(6):1849-1855.
https://doi.org/10.3390/neurolint16060132
Chicago/Turabian Style
Schirò, Giuseppe, Matteo Gastaldi, Salvatore Iacono, Silvia Scaranzin, Valentina Picciolo, Valentina Arnao, Anita Ferrari, Cesare Gagliardo, and Marco D’Amelio.
2024. "Anti-Collapsin Response Mediator Protein 5(CV2/CRMP5) and Anti-Glutamic Acid Decarboxylase (GAD) Antibodies-Mediated Encephalopathy Mimicking Atypical Parkinsonism" Neurology International 16, no. 6: 1849-1855.
https://doi.org/10.3390/neurolint16060132
APA Style
Schirò, G., Gastaldi, M., Iacono, S., Scaranzin, S., Picciolo, V., Arnao, V., Ferrari, A., Gagliardo, C., & D’Amelio, M.
(2024). Anti-Collapsin Response Mediator Protein 5(CV2/CRMP5) and Anti-Glutamic Acid Decarboxylase (GAD) Antibodies-Mediated Encephalopathy Mimicking Atypical Parkinsonism. Neurology International, 16(6), 1849-1855.
https://doi.org/10.3390/neurolint16060132
